Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scheltens

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Neurology|December 12, 2007
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCIM Ewers, K Buerger, S J Teipel, et al.
European Journal of Neurology|March 27, 2015
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's diseaseR Schmidt, E Hofer, F H Bouwman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 30, 2007
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS studyE S C Korf, E C W van Straaten, F-E de Leeuw, et al.
Alzheimer'S Research & Therapy|January 21, 2022
The behavioral variant of Alzheimer's disease does not show a selective loss of Von Economo and phylogenetically related neurons in the anterior cingulate cortexE H Singleton, Y A L Pijnenburg, P Gami-Patel, et al.
Experimental Neurology|December 17, 2009
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levelsA Petzold, M D Chapman, S Schraen, et al.
Neurobiology of Aging|June 27, 2006
Clinical significance of corpus callosum atrophy in a mixed elderly populationC Ryberg, E Rostrup, M B Stegmann, et al.
Journal of the Neurological Sciences|May 31, 2011
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohortC Ryberg, E Rostrup, O B Paulson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Grey zone amyloid burden affects memory function: the SCIENCe projectJ L Ebenau, S C J Verfaillie, K A van den Bosch, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Neurology|December 12, 2007
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCIM Ewers, K Buerger, S J Teipel, et al.
European Journal of Neurology|March 27, 2015
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's diseaseR Schmidt, E Hofer, F H Bouwman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 30, 2007
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS studyE S C Korf, E C W van Straaten, F-E de Leeuw, et al.
Alzheimer'S Research & Therapy|January 21, 2022
The behavioral variant of Alzheimer's disease does not show a selective loss of Von Economo and phylogenetically related neurons in the anterior cingulate cortexE H Singleton, Y A L Pijnenburg, P Gami-Patel, et al.
Experimental Neurology|December 17, 2009
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levelsA Petzold, M D Chapman, S Schraen, et al.
Neurobiology of Aging|June 27, 2006
Clinical significance of corpus callosum atrophy in a mixed elderly populationC Ryberg, E Rostrup, M B Stegmann, et al.
Journal of the Neurological Sciences|May 31, 2011
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohortC Ryberg, E Rostrup, O B Paulson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Grey zone amyloid burden affects memory function: the SCIENCe projectJ L Ebenau, S C J Verfaillie, K A van den Bosch, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Pageof 27